Dr Bardia on Current Approaches to HER2+ Breast Cancer Management

Current and future HER2+, HR- metastatic breast cancer treatment approachesПодробнее

Dr. Aditya Bardia on RAD1901 in ER-Positive Metastatic Breast CancerПодробнее

Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast ...Подробнее

New Approaches to Cancer Treatments Panel | 2024 NFCR Global Summit & Award CeremoniesПодробнее

How to treat HER2+ Breast Cancer in 2024 with Dr. Harold BursteinПодробнее

Addressing Current Questions and Controversies in the Management of Metastatic Breast CancerПодробнее

Guidelines and Approaches to HER2 Testing for Breast CancerПодробнее

Dr. Bardia on Dual Targeting of the HER2 ReceptorПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-ExpressingПодробнее

HER2-Positive Breast Cancer: A Paradigm Shift in Diagnosis and TherapyПодробнее

Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast CancerПодробнее

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast CancerПодробнее

Dr Praveen Paliwal | New Treatment approaches in HER2 +ve Metastatic Breast CancerПодробнее

Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast CancerПодробнее

Breast Cancer | Aditya Bardia, MD, MPHПодробнее

Overview of Clinical Data of SERDs & Their Place in Treatment LandscapeПодробнее